Advanced Search
 

Email LinkedIn Twitter

MARCH 2015 Research Alert

This month we added four new studies to the Best Practice Database, the research repository for Best Practices, LLC. Two of the new studies deliver benchmarks and insights on how functions within health economics and outcomes research (HEOR) are approaching various aspects of Big Data utilization. Another study examines how companies are optimizing internal presentations so they deliver high impact assessments for executives. The last study looks at how commercial functions approach structure and governance issues for Big Data endeavors.

The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.

Big Data Utilization across Commercial Functions Download: Big Data in Pharma: Structure and Governance for Big Data Utilization across Commercial Functions (ID 5350)
This study investigates the types of Big Data studies, the most valued partnerships and the policies that companies are using as they move to a more analytically based approach to medical decisions.
Optimizing Leadership Presentations Download: Optimizing Leadership Presentations: Crafting and Delivering High Impact Competitive Assessments and Development Briefs for Executives (ID 5353)
This study explores the critical elements and best formats for two common briefing templates: 1) the Competitive Landscape Summary Map and 2) the Development Landscape Profile Map (often described as the Data Disclosure or Clinical Trials Progress Summary).

Big Data Utilization across HOR Functions Download: Big Data in Pharma: Structure and Governance for Big Data Utilization Across Health Outcomes Research Functions (ID 5352)
Best Practices, LLC undertook this study to better understand the structure and governance approaches the biopharmaceutical sector is taking for Big Data utilization across Health Outcomes Research functions.
Big Data in Pharma Download: Big Data in Pharma: Information Types and Sources for Big Data Utilization Across Health Outcomes Research Functions (ID 5351)
Best Practices, LLC undertook this study to better understand the growing influence of Big Data in the biopharmaceutical sector and how it impacts HEOR. The study offers segmented responses from HEOR participants regarding key benchmarks around what types of data companies are using most frequently as well as the data sources they find most useful.

 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links  Product RSS Feed
  • Research & Consulting
  • Medical Affairs
  • Human Resources
    Process Improvement
  • Pharmaceutical Product
    Launch and Re-Launch
  • Benchmarking Reports
  • Excellence Services
  • Report Catalog
  • Best Practice Database
  • Medical Affairs
  • Competitive & Business Intelligence
  • Human Resources
  • Research and Advisory Services
  • Medical Affairs Consortium
  • Digital Technology Consortium
  • White Papers
  • Our Expertise
  • Medical Affairs
  • Competitive & Business Intelligence
  • Human Resource Management
  • Brand Management & Product Leadership
  • New Product launch
  • Pharmaceuticals
    • Payment gateway
    Secured by PayPal

    Follow Us: 

    linkedin twitter slideshare youtube google + pinterest

    All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
    Read our Terms and Conditions of Use, Privacy Policy and Copyright Information